Chemical Market Reports

Global Drug Discovery Technologies Market By Type (Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others), By Application (Biopharmaceutical companies, Pharmaceutical companies, Research institutes, and Biotech companies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 143269
  • 20-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Drug Discovery Technologies Market is estimated to be valued US$ XX.X million in 2019. The report on Drug Discovery Technologies Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global drug discovery technologies market is segmented on the basis of Type, Application, and geography.
    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Drug Discovery Technologies Market Scope:

    By type, the market is segmented into Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others. By Application, the market is divided into Biopharmaceutical companies, Pharmaceutical companies, Research institutes, and Biotech companies.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Agilent Technologies Inc, Abbott Laboratories, GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and Astrazeneca plc.

    Key Market Segments

    Type

    Biochips
    High throughput screening
    Pharmacogenomics
    Genomics
    Bioanalytical instruments
    Bioinformatics
    Nanotechnology
    Others

    Application

    Biopharmaceutical companies
    Pharmaceutical companies
    Research institutes
    Biotech companies

    Key Market Players included in the report:

    Agilent Technologies Inc
    Abbott Laboratories
    GE Healthcare Ltd.
    Albany Molecular Research Inc.
    Affymetrix Inc.
    Arqule Inc.
    Luminex Corporation
    Bayer Healthcare AG
    Novartis AG
    Astrazeneca plc

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Drug Discovery Technologies Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Drug Discovery Technologies Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Drug Discovery Technologies Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Drug Discovery Technologies Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Drug Discovery Technologies Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Drug Discovery Technologies Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Drug Discovery Technologies sub-markets, depending on key regions (various vital states).
    To analyze Drug Discovery Technologies Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Drug Discovery Technologies Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Drug Discovery Technologies Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content

    1. Drug Discovery Technologies Market Introduction

    1.1. Definition
    1.2. Taxonomy
    1.3. Research Scope

    2. Executive Summary

    2.1. Key Findings by Major Segments
    2.2. Top strategies by Major Players

    3. Global Drug Discovery Technologies Market Overview

    3.1. Drug Discovery Technologies Market Dynamics

    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges

    3.2. PESTLE Analysis
    3.3. Opportunity Map Analysis
    3.4. PORTER’S Five Forces Analysis
    3.5. Market Competition Scenario Analysis
    3.6. Product Life Cycle Analysis
    3.7. Opportunity Orbits
    3.8. Production Analysis by Region/Company
    3.9. Industry chain Analysis
    3.10. Marketing Strategy

    4. Global Drug Discovery Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028

    4.1. Global Drug Discovery Technologies Market Analysis by Type: Introduction
    4.2. Market Size and Forecast by Region
    4.3. Biochips

    4.4. High throughput screening

    4.5. Pharmacogenomics

    4.6. Genomics

    4.7. Bioanalytical instruments

    4.8. Bioinformatics

    4.9. Nanotechnology

    4.10. Others

    5. Global Drug Discovery Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028

    5.1. Global Drug Discovery Technologies Market Analysis by Application: Introduction
    5.2. Market Size and Forecast by Region
    5.3. Biopharmaceutical companies

    5.4. Pharmaceutical companies

    5.5. Research institutes

    5.6. Biotech companies

    6. Global Drug Discovery Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028

    6.1. North America

    6.1.1. North America Drug Discovery Technologies Market: Regional Trend Analysis

    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico

    6.2.1. Europe

    6.2.1. Europe Drug Discovery Technologies Market: Regional Trend Analysis

    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe

    6.3. Asia-Pacific

    6.3.1. Asia-Pacific Drug Discovery Technologies Market: Regional Trend Analysis

    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific

    6.4. Latin America

    6.4.1. Latin America Drug Discovery Technologies Market: Regional Trend Analysis

    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America

    6.5. Middle East and Africa

    6.5.1. Middle East and Africa Drug Discovery Technologies Market: Regional Trend Analysis

    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA

    7. Global Drug Discovery Technologies Market Competitive Landscape, Market Share Analysis, and Company Profiles

    7.1. Market Share Analysis
    7.2. Company Profiles
    7.3. Agilent Technologies#Inc

    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments

    7.4. Abbott Laboratories

    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments

    7.5. GE Healthcare Ltd.

    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments

    7.6. Albany Molecular Research Inc.

    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments

    7.7. Affymetrix Inc.

    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments

    7.8. Arqule Inc.

    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments

    7.9. Luminex Corporation

    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments

    7.10. Bayer Healthcare AG

    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments

    7.11. Novartis AG

    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments

    7.12. Astrazeneca plc

    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments

    8. Assumptions and Acronyms
    9. Research Methodology
    10. Contact

  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046